AU2003253687A1 - Liposomal hgh composition and method for administration thereof - Google Patents
Liposomal hgh composition and method for administration thereofInfo
- Publication number
- AU2003253687A1 AU2003253687A1 AU2003253687A AU2003253687A AU2003253687A1 AU 2003253687 A1 AU2003253687 A1 AU 2003253687A1 AU 2003253687 A AU2003253687 A AU 2003253687A AU 2003253687 A AU2003253687 A AU 2003253687A AU 2003253687 A1 AU2003253687 A1 AU 2003253687A1
- Authority
- AU
- Australia
- Prior art keywords
- liposomal
- administration
- hgh composition
- hgh
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41688502P | 2002-10-09 | 2002-10-09 | |
US60/416,885 | 2002-10-09 | ||
PCT/US2003/019880 WO2004032789A2 (en) | 2002-10-09 | 2003-07-28 | Liposomal hgh composition and method for administration thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003253687A8 AU2003253687A8 (en) | 2004-05-04 |
AU2003253687A1 true AU2003253687A1 (en) | 2004-05-04 |
Family
ID=32093916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003253687A Abandoned AU2003253687A1 (en) | 2002-10-09 | 2003-07-28 | Liposomal hgh composition and method for administration thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003253687A1 (en) |
WO (1) | WO2004032789A2 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5549910A (en) * | 1989-03-31 | 1996-08-27 | The Regents Of The University Of California | Preparation of liposome and lipid complex compositions |
GB9007052D0 (en) * | 1990-03-29 | 1990-05-30 | Skua Investments Ltd | Pharmaceutical formulations |
ATE164515T1 (en) * | 1993-11-05 | 1998-04-15 | Amgen Inc | PRODUCTION OF LIPOSOMES AND METHOD FOR ENCAPSULATING SUBSTANCES |
US6306433B1 (en) * | 1997-08-12 | 2001-10-23 | Pharmacia Ab | Method of preparing pharmaceutical compositions |
-
2003
- 2003-07-28 AU AU2003253687A patent/AU2003253687A1/en not_active Abandoned
- 2003-07-28 WO PCT/US2003/019880 patent/WO2004032789A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004032789A3 (en) | 2004-08-12 |
AU2003253687A8 (en) | 2004-05-04 |
WO2004032789A2 (en) | 2004-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003300025A1 (en) | Method and composition for reducing cravings for a craved substance | |
AU2003211376A1 (en) | Drug administration method | |
AU2003284115A1 (en) | Method of delivering local anesthesia | |
EP1572262A3 (en) | Method of delivering local anesthesia | |
AU2003281465A1 (en) | Composition for solubilization of paclitaxel and preparation method thereof | |
AU2002329022A1 (en) | Method and pharmaceutical composition for treating inflammation | |
AU2003284387A1 (en) | Delivery composition and method | |
AUPR510001A0 (en) | Formulation and method | |
AU2003234794A1 (en) | Composition and method for temporarily fixing solid | |
AU2003294421A1 (en) | Method for reducing or preventing modification of a polypeptide in solution | |
AUPP968699A0 (en) | Therapeutic compositions and method for their preparation | |
AU2003232044A1 (en) | Composition and method for dermatological treatment | |
AU2003278806A1 (en) | Composition and method for moisturizing nasal tissue | |
AU2002351206A1 (en) | Lateral lubistor structure and method | |
AU2003269126A1 (en) | Method of combining materials | |
AU2003304280A1 (en) | Composition and method for self-assembly and mineralization of peptide amphiphiles | |
AU2003294762A1 (en) | Film-type preparations for transmucosal administration of nicotine and method for the production thereof | |
AU2003295574A1 (en) | Method and compositions for temporarily incapaciting subjets | |
AU2002246950A1 (en) | Hydrocapsules and method of preparation | |
AU2003222364A1 (en) | Preparation for oxidation-sensitive compounds and method for making same | |
AU2002334123A1 (en) | Anaesthetic compositions and method for their administration | |
AU2003234041A1 (en) | Laminated product and method for its preparation | |
AU2570001A (en) | Pharmaceutical composition and method for its manufacture | |
AU2003257051A1 (en) | Composition and method for lowering cholesterol | |
AU2002245510A1 (en) | Method and composition for embalming |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |